Cargando…

Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?

Tuberous sclerosis complex (TSC) is an autosomal dominant and multi-system genetic disorder in humans. TSC affects around 25,000 to 40,000 individuals in the United States and about 1 to 2 million individuals worldwide, with an estimated prevalence of one in 6,000 newborns. TSC occurs in all races a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habib, Samy L, Al-Obaidi, Noor Y, Nowacki, Maciej, Pietkun, Katarzyna, Zegarska, Barbara, Kloskowski, Tomasz, Zegarski, Wojciech, Drewa, Tomasz, Medina, Edward A., Zhao, Zhenze, Liang, Sitai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039383/ https://www.ncbi.nlm.nih.gov/pubmed/27698899 http://dx.doi.org/10.7150/jca.14747

Ejemplares similares

The use of stem cells in aesthetic dermatology and plastic surgery procedures. A compact review of experimental and clinical applications
por: Nowacki, Maciej, et al.
Publicado: (2017)

A first case report of rare synchronous double cancers: malignant cutaneous melanoma and gastrointestinal stromal tumor
por: Zegarska, Barbara, et al.
Publicado: (2017)

Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis
por: Nowacki, Maciej, et al.
Publicado: (2017)

Use of Adipose-Derived Stem Cells to Support Topical Skin Adhesive for Wound Closure: A Preliminary Report from Animal In Vivo Study
por: Nowacki, Maciej, et al.
Publicado: (2016)

Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation
por: Nowacki, Maciej, et al.
Publicado: (2016)

Changes of Langerhans cells during skin ageing
por: Zegarska, Barbara, et al.
Publicado: (2017)

Air pollution, UV irradiation and skin carcinogenesis: what we know, where we stand and what is likely to happen in the future?
por: Zegarska, Barbara, et al.
Publicado: (2017)

Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes
por: Habib, Samy L., et al.
Publicado: (2014)

Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
por: Liang, Sitai, et al.
Publicado: (2014)

The TSC-mTOR pathway regulates macrophage polarization
por: Byles, Vanessa, et al.
Publicado: (2013)

Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis
por: Nowacki, Maciej, et al.
Publicado: (2015)

Schwann cells – a new hope in tissue engineered urinary bladder innervation. A method of cell isolation
por: Adamowicz, Jan, et al.
Publicado: (2011)

Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis – initial trial preliminary report
por: Nowacki, Maciej, et al.
Publicado: (2019)

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
por: Presneau, N, et al.
Publicado: (2009)

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer
por: Mrozek, Evelyn M., et al.
Publicado: (2021)

Artificial urinary conduit construction using tissue engineering methods
por: Kloskowski, Tomasz, et al.
Publicado: (2014)

Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated
por: Cabrera-López, Cristina, et al.
Publicado: (2015)

Methylation of Hypothalamic Tsc1-mTOR Signaling in Regulation of Obesity and Obesity Resistance
por: Wang, Yanli, et al.
Publicado: (2020)

Seizure reduction in TSC2‐mutant mouse model by an mTOR catalytic inhibitor
por: Dhamne, Sameer C., et al.
Publicado: (2023)

Because good enough is never good enough
por: John, M
Publicado: (2012)

Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR
por: Dere, Ruhee, et al.
Publicado: (2010)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Clinical outcomes of hyperbaric oxygen therapy in treatment of postoperative chronic Pseudomonas aeruginosa wound infection following implant reconstruction of the breast
por: Nowikiewicz, Tomasz, et al.
Publicado: (2019)

The mTOR pathway genes mTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function
por: Nguyen, Lena H., et al.
Publicado: (2023)

Ureter Regeneration–The Proper Scaffold Has to Be Defined
por: Kloskowski, Tomasz, et al.
Publicado: (2014)

Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC)
por: Brakemeier, Susanne, et al.
Publicado: (2017)

TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway
por: Jin, Shan, et al.
Publicado: (2018)

Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)

Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients
por: Habib, Samy L
Publicado: (2009)

Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination via TSC-mTOR Signaling
por: Xie, Ya-Jun, et al.
Publicado: (2018)

Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma
por: Maász, Anita, et al.
Publicado: (2023)

Vascularization Potential of Electrospun Poly(L-Lactide-co-Caprolactone) Scaffold: The Impact for Tissue Engineering
por: Jundziłł, Arkadiusz, et al.
Publicado: (2017)

The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe
por: Nowacki, Maciej, et al.
Publicado: (2018)

NOT "Good Enough for the War."
Publicado: (1916)

Good-Enough Synthesis
por: Almagor, Shaull, et al.
Publicado: (2020)

Concise Review: Tissue Engineering of Urinary Bladder; We Still Have a Long Way to Go?
por: Adamowicz, Jan, et al.
Publicado: (2017)

Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer
por: Liang, Sitai, et al.
Publicado: (2018)

TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species
por: Chen, Chong, et al.
Publicado: (2008)

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma
por: Chakraborty, Sanjukta, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_i20untg6hlc16m4947g210kuls